(HealthDay)—For patients with left main coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents is noninferior to coronary artery bypass grafting (CABG), according to a study published ...
Nov 1, 2016
0
0
Spouses of people who suffer a sudden heart attack (an acute myocardial infarction) have an increased risk of depression, anxiety, or suicide after the event, even if their partner survives, according to new research published ...
Aug 21, 2012
0
0
Brain health after COVID-19 is impaired, but no more than that seen for patients hospitalized for other medical conditions of similar severity, according to a study published online Dec. 28 in JAMA Network Open.
Dec 29, 2023
0
0
(HealthDay) -- Meta-analysis of randomized clinical trials (RCTs) suggests that drug-eluting stents (DESs) significantly reduce repeat revascularizations, with no increase in stent thrombosis (ST), mortality, or recurrent ...
Apr 4, 2012
0
0
Women with a history of diabetes in pregnancy (gestational diabetes) are at substantially higher risk of cardiovascular and cerebrovascular diseases—conditions that affect blood flow in the heart and brain—finds an analysis ...
Sep 21, 2022
0
2
OCTOBER 26, 2012 – A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of ...
Oct 26, 2012
0
0
Having diabetes doubles a person's risk of dying after a heart attack, but the reason for the increased risk is not clear. A new University of Iowa study suggests the link may lie in the over-activation of an important heart ...
Feb 15, 2013
0
0
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25 000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure ...
May 24, 2016
0
0
Recognizing and acting on heart attack symptoms is linked with faster lifesaving treatment, according to research presented at ESC Congress 2023.
Aug 22, 2023
0
1
A prespecified analysis of the MASTER DAPT trial has confirmed that the absence of ischemic risk and reduction in bleeding with abbreviated dual antiplatelet therapy (DAPT) in patients at high bleeding risk undergoing intervention ...
Aug 29, 2022
0
9
